Conn's
Conn's syndrome, also known as primary aldosteronism or primary hyperaldosteronism, is a medical condition characterized by the excessive production of the hormone aldosterone by the adrenal glands. This overproduction leads to a range of symptoms and complications primarily affecting the cardiovascular and renal systems. The condition was first described by Jerome W. Conn in 1955, hence the name Conn's syndrome.
Etiology
Conn's syndrome can be caused by various factors that lead to the overproduction of aldosterone. The most common cause is an aldosterone-producing adenoma, a benign tumor of the adrenal gland. Other causes include adrenal hyperplasia, a condition where the adrenal glands are enlarged and produce too much aldosterone, and, rarely, adrenal carcinoma, a malignant adrenal tumor. In some cases, the cause of Conn's syndrome may be genetic.
Pathophysiology
Aldosterone is a hormone that plays a crucial role in regulating blood pressure and electrolyte balance by signaling the kidneys to retain sodium and excrete potassium. In Conn's syndrome, the excessive aldosterone leads to sodium and water retention, which increases blood volume and, consequently, blood pressure. The condition also causes the kidneys to excrete too much potassium, leading to hypokalemia (low potassium levels), which can cause muscle weakness, fatigue, and, in severe cases, cardiac arrhythmias.
Symptoms
The symptoms of Conn's syndrome can vary but often include high blood pressure (hypertension), muscle weakness, fatigue, headaches, and, in cases of severe hypokalemia, cardiac arrhythmias. Some individuals may also experience increased thirst and urination due to the body's attempt to balance the effects of excessive aldosterone.
Diagnosis
The diagnosis of Conn's syndrome involves a combination of clinical evaluation, biochemical tests, and imaging studies. Initial tests often include measuring aldosterone and renin levels in the blood, with a high aldosterone-to-renin ratio suggesting primary aldosteronism. Imaging studies, such as computed tomography (CT) scans or magnetic resonance imaging (MRI), are used to identify adrenal adenomas or hyperplasia. In some cases, adrenal vein sampling may be performed to confirm the diagnosis and determine the source of aldosterone overproduction.
Treatment
Treatment for Conn's syndrome depends on the underlying cause. In cases caused by an aldosterone-producing adenoma, surgical removal of the tumor is often recommended. For patients with adrenal hyperplasia or those who cannot undergo surgery, medical management with aldosterone antagonists, such as spironolactone or eplerenone, is typically prescribed. These medications help counteract the effects of excessive aldosterone. Additionally, managing hypertension and correcting hypokalemia are important aspects of treatment.
Prognosis
With appropriate treatment, the prognosis for individuals with Conn's syndrome is generally good. Surgical removal of an aldosterone-producing adenoma can often cure the condition, while medical management can effectively control symptoms and prevent complications in those with adrenal hyperplasia or those who are not surgical candidates.
Epidemiology
Conn's syndrome is a relatively rare condition, but it is an important cause of secondary hypertension. It is estimated to affect approximately 0.5-2% of individuals with hypertension.
| Adrenal gland disorders | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This adrenal gland disorder related article is a stub.
|
| Hypertension and related topics | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Hypertension related article is a stub.
|
Conn's
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD